BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29789573)

  • 1. High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing.
    Zhang P; Xia JH; Zhu J; Gao P; Tian YJ; Du M; Guo YC; Suleman S; Zhang Q; Kohli M; Tillmans LS; Thibodeau SN; French AJ; Cerhan JR; Wang LD; Wei GH; Wang L
    Nat Commun; 2018 May; 9(1):2022. PubMed ID: 29789573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci.
    Zhang P; Tillmans LS; Thibodeau SN; Wang L
    Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31323811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.
    Tian Y; Dong D; Wang Z; Wu L; Park JY; ; Wei GH; Wang L
    Am J Hum Genet; 2023 Aug; 110(8):1289-1303. PubMed ID: 37541187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.
    Zuber V; Bettella F; Witoelar A; ; ; ; ; Andreassen OA; Mills IG; Urbanucci A
    BMC Genomics; 2017 Mar; 18(1):270. PubMed ID: 28359301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic identification of regulatory variants associated with cancer risk.
    Liu S; Liu Y; Zhang Q; Wu J; Liang J; Yu S; Wei GH; White KP; Wang X
    Genome Biol; 2017 Oct; 18(1):194. PubMed ID: 29061142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene regulatory mechanisms underpinning prostate cancer susceptibility.
    Whitington T; Gao P; Song W; Ross-Adams H; Lamb AD; Yang Y; Svezia I; Klevebring D; Mills IG; Karlsson R; Halim S; Dunning MJ; Egevad L; Warren AY; Neal DE; Grönberg H; Lindberg J; Wei GH; Wiklund F
    Nat Genet; 2016 Apr; 48(4):387-97. PubMed ID: 26950096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
    Jin HJ; Jung S; DebRoy AR; Davuluri RV
    Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.
    Jinga V; Csiki IE; Manolescu A; Iordache P; Mates IN; Radavoi D; Rascu S; Badescu D; Badea P; Mates D
    J Cell Mol Med; 2016 Apr; 20(4):594-600. PubMed ID: 26773531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set.
    Thibodeau SN; French AJ; McDonnell SK; Cheville J; Middha S; Tillmans L; Riska S; Baheti S; Larson MC; Fogarty Z; Zhang Y; Larson N; Nair A; O'Brien D; Wang L; Schaid DJ
    Nat Commun; 2015 Nov; 6():8653. PubMed ID: 26611117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphism discovery in bovine liver using RNA-seq technology.
    Pareek CS; Błaszczyk P; Dziuba P; Czarnik U; Fraser L; Sobiech P; Pierzchała M; Feng Y; Kadarmideen HN; Kumar D
    PLoS One; 2017; 12(2):e0172687. PubMed ID: 28234981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for familial and hereditary prostate cancer.
    Lynch HT; Kosoko-Lasaki O; Leslie SW; Rendell M; Shaw T; Snyder C; D'Amico AV; Buxbaum S; Isaacs WB; Loeb S; Moul JW; Powell I
    Int J Cancer; 2016 Jun; 138(11):2579-91. PubMed ID: 26638190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin interactions and candidate genes at ten prostate cancer risk loci.
    Du M; Tillmans L; Gao J; Gao P; Yuan T; Dittmar RL; Song W; Yang Y; Sahr N; Wang T; Wei GH; Thibodeau SN; Wang L
    Sci Rep; 2016 Mar; 6():23202. PubMed ID: 26979803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs.
    Yeo J; Morales DA; Chen T; Crawford EL; Zhang X; Blomquist TM; Levin AM; Massion PP; Arenberg DA; Midthun DE; Mazzone PJ; Nathan SD; Wainz RJ; Nana-Sinkam P; Willey PFS; Arend TJ; Padda K; Qiu S; Federov A; Hernandez DR; Hammersley JR; Yoon Y; Safi F; Khuder SA; Willey JC
    BMC Pulm Med; 2018 Mar; 18(1):42. PubMed ID: 29506519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotyping-in-Thousands by sequencing (GT-seq): A cost effective SNP genotyping method based on custom amplicon sequencing.
    Campbell NR; Harmon SA; Narum SR
    Mol Ecol Resour; 2015 Jul; 15(4):855-67. PubMed ID: 25476721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a high-density genetic map by specific locus amplified fragment sequencing (SLAF-seq) and its application to Quantitative Trait Loci (QTL) analysis for boll weight in upland cotton (Gossypium hirsutum.).
    Zhang Z; Shang H; Shi Y; Huang L; Li J; Ge Q; Gong J; Liu A; Chen T; Wang D; Wang Y; Palanga KK; Muhammad J; Li W; Lu Q; Deng X; Tan Y; Song W; Cai J; Li P; Rashid Ho; Gong W; Yuan Y
    BMC Plant Biol; 2016 Apr; 16():79. PubMed ID: 27067834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of prostate cancer at biopsy is predicted by a number of genetic variants.
    Kashyap A; Kluźniak W; Wokołorczyk D; Gołąb A; Sikorski A; Słojewski M; Gliniewicz B; Świtała J; Borkowski T; Borkowski A; Antczak A; Wojnar Ł; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała P; Piotrowski K; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Górski B; Masojć B; van de Wetering T; Menkiszak J; Akbari MR; Lubiński J; Narod SA; Cybulski C;
    Int J Cancer; 2014 Mar; 134(5):1139-46. PubMed ID: 24037955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
    Price DK; Chau CH; Till C; Goodman PJ; Leach RJ; Johnson-Pais TL; Hsing AW; Hoque A; Parnes HL; Schenk JM; Tangen CM; Thompson IM; Reichardt JK; Figg WD
    Cancer; 2016 Aug; 122(15):2332-40. PubMed ID: 27164191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic factors influencing prostate cancer risk in Norwegian men.
    Chen H; Ewing CM; Zheng S; Grindedaal EM; Cooney KA; Wiley K; Djurovic S; Andreassen OA; Axcrona K; Mills IG; Xu J; Maehle L; Fosså SD; Isaacs WB
    Prostate; 2018 Feb; 78(3):186-192. PubMed ID: 29181843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative Genomic Analysis Predicts Causative
    Zhang Y; Manjunath M; Zhang S; Chasman D; Roy S; Song JS
    Cancer Res; 2018 Apr; 78(7):1579-1591. PubMed ID: 29351903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.